@onjcri.org.au
We are an independent research institute focused on translational research into more effective, tolerable and accessible cancer treatments for all.
@onjcri.org.auA world-first study comparing mRNA vaccine platforms head-to-head has generated findings that could revolutionise cancer treatment and vaccine design.
La Trobe University (LaTrobeUni), Doherty Institute
#mRNALNP #CancerResearch #mRNAvaccines
@onjcri.org.auCongratulations to our CEO, Prof Marco Herold, on being elected a Fellow of the Australian Academy of Health and Medical Sciences.
A recognition of Prof Herold's scientific leadership and significant contributions to the field of cancer research.
@onjcri.org.au🛫 Dr Shiyao Li and Dr Dilshan Gunasinghe receive the ONJCRI Postdoc Domestic Travel Award, a key initiative led by our Postdoc Committee enabling our postdoctoral researchers to attend key Australian conferences and meetings.
@onjcri.org.auONJCRI, WEHI and Genentech researchers used a new CRISPR guide RNA library (Partita) and discovered that:
➡️ Switching on the Irx5 gene allowed cancer cells to survive venetoclax
️➡️ Runx2, Runx3, and Csf1r genes accelerate MYC-driven lymphoma
@onjcri.org.auThe first Australian participant has been enrolled in the global VIGOR trial, sponsored by ONJCRI in collaboration with COGNO in Australia.
The trial will investigate vorasidenib maintenance treatment in people with IDH-mutant grade 2/3 astrocytoma.
@onjcri.org.auThanks to our generous partner, Love Your Sister, every donation made to our Medical Research Giving Day campaign today will be doubled.
💛 Support our research on breast cancer in younger women: https://ow.ly/pab650ZJ2Zj
#MedicalResearchGivingDay #CancerResearch #EarlyOnsetBreastCancer
@onjcri.org.au🌏 Join us for an exclusive event focused on the cutting-edge technologies that enable research at ONJCRI to mark World Cancer Research Day.
#FreeEvent #CancerResearch #STEM #WorldCancerResearchDay #Nanomedicine #GeneEditing #AI
@onjcri.org.auONJCRI laboratory head A/Prof Lisa Mielke will join the ‘hunt’ for the causes behind the rising numbers of early-onset bowel cancer through the new Centre of Research Excellence ARTEMIS.
➡️ Learn more: https://ow.ly/rHIl50ZIvuw
@onjcri.org.au🎉 Dr Teresa Sadras has been awarded a prestigious Leukemia Research Foundation grant to initiate a new research project to identify new treatment targets for ALL that has evolved to escape immunotherapies.
@onjcri.org.auONJCRI and Adelaide University researchers found that TNBC patients with low levels of the miR-342 molecule and high activity of the E2F pathway were more likely to develop metastatic disease.
@adelaideuni.bsky.social #TNBC #CancerResearch
